A long and ugly proxy war between Masimo and activist investor Politan Capital Management is expected to come to an end Thursday at the company's annual shareholder meeting.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,